STARK PHARMACEUTICALS LIMITED
Significant control: Graham Julian Fraser-Pye (25–50%), Ian Jacobson (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Stark Pharmaceuticals Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Stark Pharmaceuticals Limited sell?
Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
STARK PHARMACEUTICALS LIMITED is an active private limited company (company number 12837365) incorporated on 25 August 2020, registered in London. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 31 December 2024 and cash of £629k, with 0 employees on average.
There are 76 companies in manufacture of pharmaceutical preparations in London with filed accounts; the median reports net assets of £100 and is 8 years old.
Ownership and control
- Graham Julian Fraser-Pye
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Ian Jacobson
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 25 August 20206 yrs ago
- Next accounts due
- 30 September 202628 days overdue
- Confirmation statement due
- 8 September 2027in 315 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- Accounts type
- Small
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | — | £629k | £40 | £1.78m | — | — | 0 |
| 31 December 2023 | — | £659k | £3,079 | £1.76m | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Current assets below creditors within one yearCurrent ratio 0.35
- Cash at bank of £50,000 or moreCash £629,244
- Incorporated five or more years agoIncorporated 25 August 2020
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 315 days
- Next accounts due28 days overdue
- Accounts period end
- Accounts period end
- Incorporated
Similar companies in London
- SPACEPHARMA LIMITEDLondon · inc. Aug 2020
- FENSTER CONSULTANTS LTDLondon · inc. Jul 2020
- CONSERV BIOSCIENCE LIMITEDLondon · inc. Oct 2020
- MED X PHARMA TECH UK LIMITEDLondon · inc. Jul 2020
- MAITRI ARTHA SHASTRA LIMITEDLondon · inc. Nov 2020
- ORBYT GROUP LTDLondon · inc. May 2020
All companies incorporated on 25 August 2020 · in Aug 2020.
Reminders for STARK PHARMACEUTICALS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.